Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
deals
national top stories
san francisco blog main
boston
clinical trials
business
eli lilly
new york blog main
new york top stories
san francisco top stories
startups
third rock ventures
vc
abbvie
abcellera
acetylon pharmaceuticals
allergan
ally bridge group
alzheimer's disease
ambys medicines
antibodies
azacitidine
beta-thalassemia
big data analytics
biopharmaceutical
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
business sponsored company news
cancer
cancer drugs
casdin capital
cell therapy
constellation pharmaceuticals
What
biotech
9
×
medicines
9
×
new
research
based
company
therapeutics
abbvie
announced
companies
developing
diseases
drug
formed
genetic
ipo
lead
million
startup
today
abbott
abcellera
abcellera’s
agreement
aiming
aims
alderley
alliance
amadeus
ambys
analysis
antibodies
antibody
approach
backed
big
bio
biologics
biopharma
black
Language
unset
Current search:
medicines
×
photo
×
biotech
×
@tech.eu
1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@venturebeat.com
6 years ago
Relay Therapeutics Secures $63 Million in Series B Financing
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center